Delivery Order SPE2DR25D2011-SPE2DR26FADLT
- Not listed
- The Defense Logistics Agency awarded a $30,704.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count) on October 22, 2025, with completion scheduled for October 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.03 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $1,822.14 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed-price, non-competitive delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,357.95 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal insert (18-pack) on December 17, 2025, with completion targeted for December 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.44 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count package) on December 10, 2025, with completion expected by December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.34 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a $1,467.14 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for Yuvafem 10 mcg vaginal inserts (18 count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's facility in...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADLTDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,286.04 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 microgram vaginal inserts (18-count). This is a firm fixed price delivery order with no set-aside designation, awarded competitively on November 26, 2025, with an ultimate completion date of November 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that supports pharmaceutical and medical supply needs across U.S. military healthcare systems globally. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of federal contracts delivering medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The Yuvafem product is a hormone replacement therapy medication, consistent with the company's role as a comprehensive pharmaceutical supplier supporting military medical readiness and troop health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/25/25 |